Pricing Log in Create free account

Biora Therapeutics, Inc. (BIORQ) vs Notable Labs, Ltd. (NTBLQ)

Biora Therapeutics, Inc. and Notable Labs, Ltd. are both Biotechnology companies. Biora Therapeutics, Inc. and Notable Labs, Ltd. are of similar size ($2.5M and $2.4M). Biora Therapeutics, Inc. grew revenue faster over the last twelve months: 347.0% against −129.0%. Notable Labs, Ltd. has the higher net margin (6,350.6% vs −3,527.9%) and the lower return on invested capital (−295.4% vs 0.00%). Across the 14 metrics below, Notable Labs, Ltd. leads on 9 and Biora Therapeutics, Inc. on 5.

Valuation

Metric BIORQ NTBLQ Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.25 0.64
EV/Sales 67.44 23.30 9.21
Earnings yield 0.00% 0.00% (33.15%)
Free cash flow yield 0.00% 0.00% (25.50%)

Profitability

Metric BIORQ NTBLQ Biotechnology median
Gross margin 85.79% 116.87% 65.16%
Operating margin (6,809.06%) 9,259.04% 0.00%
Net margin (3,527.85%) 6,350.60% 0.00%
Free cash flow margin (5,165.88%) 9,158.43% 0.00%
Return on equity 27.98% (79.79%) (56.36%)
Return on assets (128.19%) (59.14%) (48.04%)
Return on invested capital 0.00% (295.36%) 0.00%

Growth

Metric BIORQ NTBLQ Biotechnology median
Revenue growth (TTM) 347.00% (129.02%) 6.02%
EPS growth (last fiscal year) (57.40%) 84.47% 30.26%
Revenue growth, 5-year CAGR (87.44%) (11.93%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BIORQ NTBLQ Biotechnology median
Debt to equity (0.18) 0.03 0.00
Current ratio 0.05 2.77 4.72
Net debt to EBITDA (0.47) 0.80 0.96

Dividend

Metric BIORQ NTBLQ Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BIORQ NTBLQ Biotechnology median
Market cap 2.49m 2.39m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack